Genetic Technologies Ltd
F:DU8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Genetic Technologies Ltd
F:DU8
|
AU |
Intrinsic Value
The intrinsic value of 
Genetic Technologies Ltd (DU8) under the Base Case is 0.001 EUR per share.
Compared with the current market price of 0.001 EUR, the stock appears
Overvalued by 30% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Genetic Technologies Does
Genetic Technologies Ltd is a molecular diagnostics company that develops and sells DNA-based tests, mainly for assessing a person’s inherited risk of disease. Its core products use genetic markers to help doctors and patients understand cancer risk, with a strong focus on breast and colorectal cancer. The company turns laboratory science into tests that can be ordered by healthcare providers and used to guide screening decisions.
- Headquarters
- Australia AU
- Employees
- 55
- IPO date
- Jul 30, 1987
Earnings Waterfall
Genetic Technologies Ltd
The intrinsic value for Genetic Technologies Ltd (DU8) under the Base Case is 0.001 EUR.
Compared with the current market price of 0.001 EUR, the stock appears Overvalued by 30% .